Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2005443rdf:typepubmed:Citationlld:pubmed
pubmed-article:2005443lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:2005443lifeskim:mentionsumls-concept:C0010075lld:lifeskim
pubmed-article:2005443lifeskim:mentionsumls-concept:C0012582lld:lifeskim
pubmed-article:2005443lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:2005443lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2005443lifeskim:mentionsumls-concept:C0303322lld:lifeskim
pubmed-article:2005443pubmed:issue3lld:pubmed
pubmed-article:2005443pubmed:dateCreated1991-4-19lld:pubmed
pubmed-article:2005443pubmed:abstractTextA same-day double injection protocol employing 99mTc-methoxyisobutyl isonitrile (MIBI) and myocardial single-photon emission computed tomography (SPECT) for detecting coronary artery disease (CAD) was assessed in 30 patients. SPECT was performed 1 hr after a first injection (250 MBq) of 99mTc-MIBI, given after 0.56 mg/kg dipyridamole (DPD) infusion. Patients were then reinjected at rest (750 MBq) and were reimaged 1 hr later. Within 1 wk, all patients underwent a complete stress-rest SPECT thallium study. Of the 330 myocardial segments evaluated, 25 were judged ischemic by both techniques, while persistent defects were demonstrated in 50 and in 47 with 99mTc-MIBI and 201TI, respectively. Six regions were considered for diseased vessels identification. Sensitivity and specificity for CAD were 100% and 75%, respectively, for both 201TI and 99mTc-MIBI. Sensitivity for identification of diseased vessels by 201TI was 68% for LAD, 89% for RCA, and 80% for LCX as opposed to 75%, 89% and 80%, respectively, by 99mTc-MIBI. Specificity was 93% in both cases for LAD, 73% and 63% for RCA, and 53% and 46% for LCX.lld:pubmed
pubmed-article:2005443pubmed:languageenglld:pubmed
pubmed-article:2005443pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2005443pubmed:citationSubsetIMlld:pubmed
pubmed-article:2005443pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2005443pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2005443pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2005443pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2005443pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2005443pubmed:statusMEDLINElld:pubmed
pubmed-article:2005443pubmed:monthMarlld:pubmed
pubmed-article:2005443pubmed:issn0161-5505lld:pubmed
pubmed-article:2005443pubmed:authorpubmed-author:MagnaniBBlld:pubmed
pubmed-article:2005443pubmed:authorpubmed-author:FranchiRRlld:pubmed
pubmed-article:2005443pubmed:authorpubmed-author:MonettiNNlld:pubmed
pubmed-article:2005443pubmed:authorpubmed-author:TartagniFFlld:pubmed
pubmed-article:2005443pubmed:authorpubmed-author:DondiMMlld:pubmed
pubmed-article:2005443pubmed:authorpubmed-author:MaielloLLlld:pubmed
pubmed-article:2005443pubmed:authorpubmed-author:LimonettiPPlld:pubmed
pubmed-article:2005443pubmed:issnTypePrintlld:pubmed
pubmed-article:2005443pubmed:volume32lld:pubmed
pubmed-article:2005443pubmed:ownerNLMlld:pubmed
pubmed-article:2005443pubmed:authorsCompleteYlld:pubmed
pubmed-article:2005443pubmed:pagination369-76lld:pubmed
pubmed-article:2005443pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:meshHeadingpubmed-meshheading:2005443-...lld:pubmed
pubmed-article:2005443pubmed:year1991lld:pubmed
pubmed-article:2005443pubmed:articleTitleDipyridamole technetium-99m-2-methoxy isobutyl isonitrile tomoscintigraphic imaging for identifying diseased coronary vessels: comparison with thallium-201 stress-rest study.lld:pubmed
pubmed-article:2005443pubmed:affiliationIstituto di Malattie Cardiovascolari, Universita' di Bologna, Italy.lld:pubmed
pubmed-article:2005443pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2005443pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2005443lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2005443lld:pubmed